Targeting Metabolic Pathways to Direct T-Cell Trafficking: Therapeutic Perspectives
Despite advances in immunomodulatory therapies, dysregulated T-cell trafficking persists as a pathological cornerstone in chronic inflammation, autoimmunity, and cancer. This spatially precise navigation—orchestrated by receptor–ligand cascades—ensures immune surveillance but drives disease when impaired. Targeting ind...